| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
7e-05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0009 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |